Concepedia

Publication | Open Access

Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent

27

Citations

19

References

2010

Year

Abstract

CYT997 was well tolerated at doses that were associated with pharmacodynamic evidence of vascular disruption in tumours.

References

YearCitations

Page 1